DOI QR코드

DOI QR Code

Detection of Human Papillomavirus in Male and Female Urine by Electrochemical DNA Chip and PCR Sequencing

  • Nilyanimit, Pornjarim (Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University) ;
  • Wanlapakorn, Nasamon (Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University) ;
  • Niruthisard, Somchai (Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University) ;
  • Pohthipornthawat, Natkrita (Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University) ;
  • Karalak, Anant (Department of Pathology, National Cancer Institute) ;
  • Laowahutanont, Piyawat (Department of Pathology, National Cancer Institute) ;
  • Phanuphak, Nittaya (The Thai Red Cross AIDS Research Centre) ;
  • Gemma, Nobuhiro (Research and Development Center) ;
  • Poovorawan, Yong (Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University)
  • Published : 2013.09.30

Abstract

Background: Cervical cancer is the second most common cancer in Thai women after breast cancer. Currently, the Papanicolaou (Pap) smear is the recommended procedure for cervical cancer screening in Thailand, but only a relatively small percentage of women follow this screening program. An alternative method to detect HPV genotypes associated with cervical cancer is self-sampling of urine, which is a more widely accepted method. Our study aimed to evaluate the prevalence of HPV in Thai women using urine and cervical swabs and prevalence of HPV in Thai men using urine samples. Materials and Methods: Tumorigenic HPV detection was accomplished by electrochemical DNA chip and PCR/direct sequencing. In addition to HPV prevalence, we report the concordance between different methods and sample types. One-hundred and sixteen women and 100 men were recruited. Histological examination revealed normal cytology in 52 women, atypical squamous cells of undetermined significance (ASCUS) in 9, low-grade squamous intraepithelial lesions (LSIL) in 24, and high-grade squamous intraepithelial lesions (HSIL) in 31. One-hundred men were classified as heterosexuals (n=45) and homosexuals (n=55). Results: The most prevalent HPV genotype in our study was HPV16. The HPV detection rate was generally lower in urine samples compared with cervical samples. Overall, there was good agreement for the detection of carcinogenic HPV from female cervical samples between the DNA chip and PCR/sequencing, with 88.8% total agreement and a kappa value of 0.76. In male urine samples, the level of agreement was higher in heterosexuals compared with homosexuals. Conclusions: Further improvement is required to increase an overall yield of HPV DNA detection in urine samples before clinical application of a urine-based HPV screening program. The electrochemical DNA chip test is a promising technique for carcinogenic HPV detection.

Keywords

HPV;HPV genotyping;cervical cancer;urine;electrochemical DNA chip

References

  1. Barzon L, Militello V, Pagni S, et al (2010). Distribution of human papillomavirus types in the anogenital tract of females and males. J Med Virol, 82, 1424-30. https://doi.org/10.1002/jmv.21733
  2. Bissett SL, Howell-Jones R, Swift C, et al (2011). Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol, 83, 1744-51. https://doi.org/10.1002/jmv.22167
  3. Brinkman JA, Jones WE, Gaffga AM, et al (2002). Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J Clin Microbiol, 40, 3155-61. https://doi.org/10.1128/JCM.40.9.3155-3161.2002
  4. Brinkman JA, Rahmani MZ, Jones WE, et al (2004). Optimization of PCR based detection of human papillomavirus DNA from urine specimens. J Clin Virol, 29, 230-40. https://doi.org/10.1016/S1386-6532(03)00157-4
  5. Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, et al (2010). Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev, 11, 117-22.
  6. Chansaenroj J, Theamboonlers A, Chinchai T, et al (2012). High-risk human papillomavirus genotype detection by electrochemical DNA chip method. Asian Pac J Cancer Prev, 13, 1151-8. https://doi.org/10.7314/APJCP.2012.13.4.1151
  7. Daponte A, Pournaras S, Mademtzis I, et al (2006). Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology. J Clin Virol, 36, 189-93. https://doi.org/10.1016/j.jcv.2006.03.009
  8. De Antonio JC, Fernandez-Olmos A, Mercadillo M, et al (2008). Detection of high-risk human papillomavirus by two molecular techniques: hybridcapture and linear array. J Virol Methods, 149, 163-6. https://doi.org/10.1016/j.jviromet.2008.01.021
  9. Fahey MI, Irwig L, Macaskill P (1995). Meta-analysis of Pap test accuracy. Am J Epidemiol, 141, 680-9. https://doi.org/10.1093/oxfordjournals.aje.a117485
  10. Geddy PM, Wells M, Lacey CJ (1993). Lack of detection of human papillomavirus DNA in male urine samples. Genitourin Med, 69, 276-9.
  11. Gheit T, Tommasino M (2011). Detection of high-risk mucosal human papillomavirus DNA in human specimens by a novel and sensitive multiplex PCR method combined with DNA microarray. Methods Mol Biol, 665, 195-212.
  12. Goldstone S, Palefsky JM, Giuliano AR, et al (2011). Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis, 203, 66-74. https://doi.org/10.1093/infdis/jiq016
  13. Gravitt PE, Peyton CL, Alessi TQ, et al (2000). Improved amplification of genital human papillomaviruses. J Clin Microbiol, 38, 357-61.
  14. Gupta A, Arora R, Gupta S, et al (2006). Human papilloma virus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimen. J Clin Microbiol, 37, 190-4.
  15. Hadzisejdic I, Simat M, Bosak A, et al (2006). Prevalence of human papillomavirus genotypes in cervical cancer and precursor lesions. Coll Antropol, 30, 879-83.
  16. Hagiwara M, Sasaki H, Matsuo K, et al (2007). Loop-mediated isothermal amplification method for detection of human papillomavirus type 6, 11, 16, and 18. J Med Virol, 79, 605-15. https://doi.org/10.1002/jmv.20858
  17. Khan MJ, Castle PE, Lorincz AT, et al (2005). The elevated 10- year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst, 97, 1072-9. https://doi.org/10.1093/jnci/dji187
  18. Koutsky L (1997). Epidemiology of genital human papillomavirus infection. Am J Med, 102, 3-8.
  19. Lurchachaiwong W, Junyangdikul P, Payungporn S, et al (2009). Relationship between hybrid capture II ratios and DNA amplification of E1, E6 and L1 genes used for the detection of human papillomavirus in samples with different cytological findings. Asian Pac J Allergy Immunol, 27, 217-24.
  20. Mandelblatt JS, Lawrence WF, Gaffikin L, et al (2002). Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. J Natl Cancer Inst, 94, 1469-83. https://doi.org/10.1093/jnci/94.19.1469
  21. Manhart LE, Holmes KK, Koutsky LA, et al (2006). Human papillomavirus infection among sexually active young women in the United States: implications for developing a vaccination strategy. Sex Transm Dis, 33, 502-8 https://doi.org/10.1097/01.olq.0000204545.89516.0a
  22. Mori S, Nakao S, Kukimoto I, et al (2011). Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers. Cancer Sci, 102, 1223-7. https://doi.org/10.1111/j.1349-7006.2011.01922.x
  23. Munoz M, Camargo M, Soto-De Leon SC, et al (2013). Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples. PLoS One, 8, 56509 https://doi.org/10.1371/journal.pone.0056509
  24. Munoz N, Bosch FX, de Sanjose S, et al (2003). International agency for research on cancer multicenter cervical cancer study group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27. https://doi.org/10.1056/NEJMoa021641
  25. Onuki M, Matsumoto K, Satoh T, et al (2009). Human papillomavirus infections among Japanese women: agerelated prevalence and type-specific risk for cervical cancer. Cancer Sci, 100, 1312-6. https://doi.org/10.1111/j.1349-7006.2009.01161.x
  26. Phanuphak N, Teeratakulpisarn N, Pankam T, et al (2013). Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence. J Acquir Immune Defic Syndr, 63, 472-9. https://doi.org/10.1097/QAI.0b013e3182918a5a
  27. Qu W, Jiang G, Cruz Y, et al (1997). PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol, 35, 1304-10.
  28. Rugpao S, Koonlertkit S, Ruengkrist T, et al (2009). ThinPrep Pap-smear and cervical intraepithelial neoplasia in reproductive-aged Thai women. J ObstetGynaecol Res, 35, 551-4.
  29. Satoh T, Matsumoto K, Fujii T, et al (2013). Rapid genotyping of carcinogenic human papillomavirus by loop-mediated isothermal amplification using a new automated DNA test (Clinichip $HPV^{TM}$). J Virol Methods, 188, 83-93. https://doi.org/10.1016/j.jviromet.2012.10.014
  30. Sellors JW, Lorincz AT, Mahony JB, et al (2000). Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ, 163, 513-8.
  31. Solomon D, Davey D, Kurman R, et al (2002). Forum group members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA, 287, 2114-9. https://doi.org/10.1001/jama.287.16.2114
  32. Song ES, Lee HJ, Hwang TS (2007). Clinical efficacy of human papilloma viruses DNA detection in urine from patients with various cervical lesions. J Korean Med Sci, 22, 99-104. https://doi.org/10.3346/jkms.2007.22.1.99
  33. Wang JL, Yang YZ, Dong WW, et al (2013). Application of human papillomavirus in screening for cervical cancer and precancerous lesions. Asian Pac J Cancer Prev, 14, 2979-82. https://doi.org/10.7314/APJCP.2013.14.5.2979
  34. Wright TC Jr, Schiffman M, Solomon D, et al (2004). Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol, 103, 304-9. https://doi.org/10.1097/01.AOG.0000109426.82624.f8

Cited by

  1. A PCR-based microwell-plate hybrid capture assay for high-risk human papillomavirus vol.159, pp.12, 2014, https://doi.org/10.1007/s00705-014-2186-0
  2. Comparison of Detection Sensitivity for Human Papillomavirus between Self-collected Vaginal Swabs and Physician-collected Cervical Swabs by Electrochemical DNA Chip vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10809
  3. Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay vol.5, pp.2167-8359, 2017, https://doi.org/10.7717/peerj.3910
  4. Detection and genotyping of HPV in urine samples from Chilean women attending primary health care centers pp.1432-1831, 2017, https://doi.org/10.1007/s00430-017-0530-1